Latest News and Events
Filter by
Selections
September 29, 2021
Arrowhead Pharmaceuticals to Participate in Upcoming October 2021 Conferences
Read MoreSeptember 1, 2021
Arrowhead Pharmaceuticals to Participate in Upcoming September 2021 Conferences
Read MoreJuly 29, 2021
Arrowhead Pharmaceuticals Receives Breakthrough Therapy Designation from U.S. FDA for ARO-AAT for the Treatment of Alpha-1 Antitrypsin Deficiency Associated Liver Disease
Read MoreJuly 14, 2021
Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Read MoreJuly 6, 2021